Ramírez-Rosales A, Góngora-Rivera F, García-Pompermayer M, Rodríguez-Robles L, Velarde-Magaña G

Idioma: Español
Referencias bibliográficas: 34
Paginas: 275-280
Archivo PDF: 188.76 Kb.

RESUMEN

El síndrome de Vogt-Koyanagi-Harada es una enfermedad autoinmune multisistémica caracterizada por la asociación de manifestaciones inflamatorias oculares bilaterales (uveítis, desprendimiento exudativo de retina) y lesiones extraoculares como meningismo, afectación dérmica y neurológica, incluyendo nervios craneales. Presentamos el caso de una joven mujer hispana con este síndrome, y una revisión de los criterios de diagnóstico, tratamiento y pronóstico.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Brazis P, Stewart M, Lee A. The Uveo-Meningeal Syndromes. Neurologist 2004; 10: 171-84.

2. Opremcak EM, Cunningham ET, Foster CS, Forster D, Moorthy RS, Lopatynsky M. Intraocular inflammation and uveitis. Basic and Clinical Science Course. Vol. 9. American Academy of Ophthalmology; 2003-2004, p. 200-3.

3. Vasudeo M, Biswas J, Ganesh S. Analysis of 87 Cases with Vogt-Koyanagi- Harada Disease. Japan J Ophthalmol 2000; 44: 296-301.

4. Ondrey FG, Moldestad E, Mastroianni MA, et al. Sensorineural hearing loss in Vogt Koyanagi Harada syndrome. Laryngoscope 2006; 116: 1873-6.

5. Choczaj-Kukula A, Janniger C. Vogt Koyanagi Harada Syndrome. En: eMedicine Specialties; Dermatology; Pediatric Diseases 2009.

6. Alaoui Z, Benamour S, El Kabli H, Amraoui A. Vogt Koyanagi Harada syndrome. Eightcases. Rev Med Internet 2007; 28: 250-4.

7. Blanc F, Fleury M, Talmant V, Deroide N, Szwarcberg J, Tranchant C. Vogt Koyanagi Harada syndrome. Rev Neurol 2005; 161: 1079-90.

8. Mejia LJ, Tobar L. Síndrome de Vogt Koyanagi Harada. Reporte de un caso. N. Acta otorrinolaringol. Cir Cabeza Cuello 2002; 30: 161-4.

9. Araneda L, Castro A. Síndrome de Vogt Koyanagi Harada. Cuadernos de Neurología; 1997; XXII.

10. Read R, Rao N, Cunningham Jr E. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000; 11: 437-42.

11. Pino RV, Pardo RG, Rodríguez CM, Iglesias GRJ, del Castillo BF. Vogt Koyanagi Harada syndrome. Report of a case with hearingloss, tinnitus, and vertigo associated to uveitis. An Otorrinolaringol Ibero Am 2007; 34: 281-5.

12. Sil A, Chatrath P, Gatland DJ. Deafnessin Vogt Koyanagi Harada syndrome. J Laryngol Otol 2006; 120: 416-8.

13. Ramos MA, Ruiz MF, Criado MD, Gómez GJL, González M. Vogt Koyanagi- Harada syndrome; a model of autoimmune neurosensory hypoacusia. Acta Otorrinolaringol Esp 1989; 40: 247-50.

14. Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology 2010; 117: 591-9.

15. Russel W, et al. International Workshop on Vogt Koyanagi Harada Disease. Revised Diagnostic Criteria for Vogt-Koyanagi-Harada Disease. Am J Ophthalmol 2001; 131: 647-52.

16. Rao NA. Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007; 27: 81-5.

17. Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131: 607-14.

18. Di Preta EA, Smith KJ, Williams J, Skelton AH. Histopathologic findings in the alopecia associated with Vogt-Koyanagi-Harada disease. J Cutan Med Surg 2000; 4: 156-60.

19. Rao NA, Inomata H, Moorthy RS. Vogt Koyanagi Harada syndrome. Pepose J, Holland GN, Wilhelmus K (eds.). Ocular infection and immunity. St. Louis, MO: Mosby-Year Book; 1996: p. 734-53.

20. Moorthy RS, Inomata H, Rao NA. Vogt Koyanagi Harada syndrome. Surv Ophthalmol 1995; 39: 265-92.

21. Díaz-Llopis M, Salom D, Hernández ML. Síndrome de Vogt-Koyanagi-Harada, actualización. Studium Ophthalologicum 2004; 22: 157-66.

22. Díaz LlM, Amselem L, Romero FJ, García-Delpech S, Hernández ML. Tratamiento con adalimumab del síndrome de Vogt-Koyanagi-Harada. Arch Soc Esp Oftalmol 2007; 82: 131-2.

23. Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M. Rituximab in refractory Vogt- Koyanagi-Harada disease. J Ophthalmic Inflamm Infect 2011; 1: 177-80.

24. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt Koyanagi-Harada’s disease. Jpn J Ophthalmol 1988; 32: 334-43.

25. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131: 599-606.

26. Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D, Abu El-Asrar AM. Prognostic factors in Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007; 27: 201-10.

27. Soo-Phaik Chee, Aliza Jap, Kristine Bacsal. Prognostic factors of Vogt-Koyanagi- Harada disease in Singapore. Am J Ophthalmol 2009; 147(1): 154-61.

28. Sheu SJ, Kou HK, Chen JF. Signiûcant prognostic factors for Vogt- Koyanagi-Harada disease in the early stage. Kaohsiung J Med Sci 2004; 20: 97-104.

29. Rathinam SR, Vijayalakshmi P, Namperumalsamy P, Nozik RA, Cunningham ET Jr. Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inûamm 1998; 6: 155-61.

30. Tabbara KF, Chavis PS, Freeman WR. Vogt-KoyanagiHarada syndrome in children compared to adults. Acta Ophthalmol Scand 1998; 76: 723-26.

31. Al Dousary S. Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease. J Laryngol Otol 2011; 125: 138-41.

32. Ondrey FG, Moldestad E, Mastroianni MA. Sensorineural Hearingloss in Vogt- Koyanagi-Harada syndrome. Laryngoscope 2006; 116: 1873-76.

33. Rodríguez RV, Garrigues HP, Gallego PR. [Sensorineural hearing loss evolution in Vogt-Koyanagi-Harada syndrome]. Acta Otorrinolaringol Esp 2011; 62: 465-8.

34. Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ, et al. Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: A randomized controlled trial. JAMA 2003; 290: 1875-83.